Cambridge Major Laboratories has acquired ChemShop BV, a supplier of API development services, and plans to invest millions of dollars to expand the company's facilities.
Cambridge Major Laboratories (US) has acquired ChemShop BV (the Netherlands), a supplier of API development services. The newly combined company has over 140 employees at 3 sites in the US and Europe. ChemShop will adopt the name Cambridge Major Laboratories Europe.
All of ChemShop's management and personnel will continue to operate the business at the pre-existing Weert (Netherlands) facility, which includes R&D laboratories, GMP kilo lab suites, and a GMP pilot plant.
Cambridge Major plans to invest several million dollars to expand the European site to include more reactor capacity, laboratories, and expansion of the company's high potency API ("HPAPI") manufacturing capabilities. The planned expansion will commence immediately and be completed in the second half of 2008.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.